Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

Healthcare Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > Words to remember. Especially those invested in Medipharm
View:
Post by mdjbrown on Feb 03, 2024 8:51am

Words to remember. Especially those invested in Medipharm

“The stock market is a device for transferring money from the impatient to the patient.”

Warren Buffett
Comment by subaru1i on Feb 03, 2024 9:43am
Excellent post, Athea and I both agree.   I kind of figured out the way Pidduck works.   He sets the stage by telling us of news for Q4, 2023 regarding generic Epidiolex approval in Brazil and instead we get the incentive compensation package press release on Dec 22 for 2023 and 2024 being paid out.   As soon as the brain triggers the question: 'what the heck is ...more  
Comment by mdjbrown on Feb 03, 2024 6:16pm
s1i, the human race is certainly trying our best to push mother nature beyond the brink, and why I believe we will see more and more aggresive diseases like CWD as a natural form of culling our over vastly populated planet.  Hunters of big game should really take notice of the latest concern out there.  Not to be a doom and gloomer, but I cant think of a worse way to spend my final days ...more  
Comment by subaru1i on Feb 03, 2024 7:29pm
I think we are in a quiet period w.r.t. LABS.  20 million new cancer cases this past year alone and it's accelerating faster than traditional drug development can keep up with.   NDA on cancer with Pfizer and we rocket to over $20 for fun.    mdj...CWD can lie dormant in humans for up to a year before surfacing.  How many hunters have eaten deer, elk, moose, etc ...more  
Medipharm Labs Corp
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities